Non-nucleoside reverse transcriptase inhibitors emerging as an attractive alternative to protease inhibitors in HIV combination therapy regimens
2011 ◽
Vol 22
(1)
◽
pp. 134-141
◽
2019 ◽
Vol 54
(4)
◽
pp. 487-490
◽
1996 ◽
Vol 93
(23)
◽
pp. 13152-13157
◽
2004 ◽
Vol 805
(2)
◽
pp. 241-247
◽
Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?
2000 ◽
Vol 1
(Supplement 1)
◽
pp. 7-10
◽
2019 ◽
Vol 54
(1)
◽
pp. 35-42
◽